论文部分内容阅读
该文对高血压伴2型糖尿病患者进行交叉试验研究,比较奥美沙坦(40mg/d)和替米沙坦(80mg/d)对其血压和代谢方面的影响。36例研究对象中20例为男性,16例为女性,均患2型糖尿病,血压未能达到<130/80mmHg(1mmHg=0.133kPa),给予奥美沙坦40mg/d或替米沙坦80mg/d降压治疗8周或以上。主要观察指标为血压下降率,次要观察指标为体质量指数、糖代谢参数、高分子量脂联素、高敏反
In this paper, a cross-sectional study of patients with type 2 diabetes mellitus with hypertension was conducted to compare the effects of olmesartan (40 mg / d) and telmisartan (80 mg / d) on blood pressure and metabolism. Of the 36 study subjects, 20 were male and 16 were female with type 2 diabetes. Blood pressure did not reach <130/80 mmHg (1 mmHg = 0.133 kPa), 40 mg of olmesartan or 80 mg / d Antihypertensive treatment for 8 weeks or more. The main observation indicators for the rate of decline in blood pressure, secondary indicators of body mass index, glucose metabolism parameters, high molecular weight adiponectin, high sensitivity